Revolution Medicines director Elizabeth M. Anderson disposes of $1,949,321.86 in common shares

• Elizabeth M. Anderson, director, cut her direct stake in Revolution Medicines common stock to 4,333 shares on Sep. 22, 2026.
• The change followed option exercise of 5,070 shares at USD 1.12, then sales totaling 10,143 shares at USD 191.8521-USD 195.15.
• Derivative holdings fell to 1,095 stock options exercisable at USD 1.12, expiring Apr. 19, 2028.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Revolution Medicines Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001758247-26-000004), on September 24, 2026, and is solely responsible for the information contained therein.